Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Heart (British Cardiac Society)|October 6, 2021
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation RegistryFrancesco Santoro, Ivan Javier Nuñez-Gil, Enrica Vitale, et al.
European Heart Journal. Acute Cardiovascular Care|October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMIFederico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
American Heart Journal|April 12, 2021
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registryIván J Núñez-Gil, Iván Olier, Gisela Feltes, et al.
International Journal of Cardiology|December 7, 2023
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registryEdoardo Elia, Francesco Bruno, Gabriele Crimi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Journal of the American Heart Association|July 25, 2023
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS RegistryFrancesco Bruno, Giorgio Marengo, Ovidio De Filippo, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
The American Journal of Cardiology|September 21, 2023
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF ScoreFabrizio D'Ascenzo, Enrico Fabris, Caterina DeGregorio, et al.
Pageof 10